Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What are all the things that aspirin does?

Literature DB >> 12969898

What are all the things that aspirin does?

Rod Flower.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2003 PMID： 12969898 PMCID： PMC194070 DOI： 10.1136/bmj.327.7415.572

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

12 in total

1. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors: J R Vane
Journal: Nat New Biol Date: 1971-06-23

2. Risk of Alzheimer's disease and duration of NSAID use.

Authors: W F Stewart; C Kawas; M Corrada; E J Metter
Journal: Neurology Date: 1997-03 Impact factor: 9.910

Review 3. Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer.

Authors: J R Paterson; J R Lawrence
Journal: QJM Date: 2001-08

Review 4. Aspirin and cancer risk: an update to 2001.

Authors: C Bosetti; S Gallus; C La Vecchia
Journal: Eur J Cancer Prev Date: 2002-12 Impact factor: 2.497

5. Anti-inflammatory drugs protect against Alzheimer disease at low doses.

Authors: G A Broe; D A Grayson; H M Creasey; L M Waite; B J Casey; H P Bennett; W S Brooks; G M Halliday
Journal: Arch Neurol Date: 2000-11

Review 6. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

Authors: Michael J Thun; S Jane Henley; Carlo Patrono
Journal: J Natl Cancer Inst Date: 2002-02-20 Impact factor: 13.506

7. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

Authors: W L Xie; J G Chipman; D L Robertson; R L Erikson; D L Simmons
Journal: Proc Natl Acad Sci U S A Date: 1991-04-01 Impact factor: 11.205

Review 8. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.

Authors: Douglas A Corley; Karla Kerlikowske; Rajiv Verma; Patricia Buffler
Journal: Gastroenterology Date: 2003-01 Impact factor: 22.682

9. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Authors: J A Mitchell; P Akarasereenont; C Thiemermann; R J Flower; J R Vane
Journal: Proc Natl Acad Sci U S A Date: 1993-12-15 Impact factor: 11.205

10. NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line.

Authors: Feng Gao; Kelly R Bales; Richard C Dodel; Junyi Liu; Xianming Chen; Harald Hample; Martin R Farlow; Steven M Paul; Yansheng Du
Journal: Brain Res Mol Brain Res Date: 2002-09-30

12 in total

1. Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response.

Authors: Ahsan F Malik; Rafaz Hoque; Xinshou Ouyang; Ayaz Ghani; Enping Hong; Khadija Khan; Laura Beth Moore; Gilbert Ng; Fay Munro; Richard A Flavell; Yan Shi; Themis R Kyriakides; Wajahat Z Mehal
Journal: Proc Natl Acad Sci U S A Date: 2011-11-22 Impact factor: 11.205

2. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.

Authors: Kevin M Poindexter; Susanne Matthew; Ida Aronchik; Gary L Firestone
Journal: Cell Biol Toxicol Date: 2016-04-07 Impact factor: 6.691

Review 3. Aspirin for in vitro fertilisation.

Authors: Charalampos S Siristatidis; George Basios; Vasilios Pergialiotis; Paraskevi Vogiatzi
Journal: Cochrane Database Syst Rev Date: 2016-11-03

What are all the things that aspirin does?

1. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

2. Risk of Alzheimer's disease and duration of NSAID use.

Review 3. Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer.

Review 4. Aspirin and cancer risk: an update to 2001.

5. Anti-inflammatory drugs protect against Alzheimer disease at low doses.

Review 6. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

7. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

Review 8. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.

9. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

10. NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line.

1. Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response.

2. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.

Review 3. Aspirin for in vitro fertilisation.

4. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.

5. Potential contribution of aspirin to cancer control programmes.

6. Effect of aspirin on cell growth of human MG-63 osteosarcoma line.

Review 7. Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation.

Review 8. Pharmacologically pertinent period of effect (PPPE).

Review 9. Lipids and Antiplatelet Therapy: Important Considerations and Future Perspectives.

Review 10. From NSAIDs to Glucocorticoids and Beyond.